SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NSIX -- Neuromedical Systems, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TLWatson59 who wrote (126)3/16/1999 6:30:00 PM
From: TLWatson59  Read Replies (1) of 137
 
Is this the prelude to the final curtain?

SOURCE: Neuromedical Systems, Inc.

NSI Netherlands, B.V. Enters Moratorium Period; Ceasing of German Operations

UPPER SADDLE RIVER, N.J., March 16 /PRNewswire/ -- Neuromedical Systems, Inc. (NSI) (Nasdaq: NSIX - news) today announced that a Netherlands court has granted NSI Netherlands, B.V.'s application for a moratorium, and has appointed an administrator. During the moratorium, NSI Netherlands, B.V. will evaluate its options, including whether to continue operations or to commence insolvency proceedings. NSI Netherlands B.V. serves as the Company's base of European operations.

''Due to disappointing 4th quarter results, we felt it was necessary to reassess our opportunities in Europe, and the moratorium allows us to do so,'' said Paul R. Sohmer, M.D., President and CEO of NSI. In connection with this reassessment, the Company has also decided to cease its operations in Germany.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext